BOULDER, Colo. -- (Business Wire)
Clovis Oncology, Inc. (NASDAQ: CLVS) will announce its third quarter
2018 financial results on Tuesday, October 30, 2018, after the close of
the U.S. financial markets. Clovis’ senior management will host a
conference call and live audio webcast at 4:30 p.m. ET to discuss the
company’s results in greater detail.
The conference call is being webcast and can be accessed from the Clovis
Oncology website at www.clovisoncology.com.
A replay of the webcast will be available for 30 days.
Conference Call Details
Clovis will hold a conference call to discuss third quarter 2018 results
on October 30 at 4:30 p.m. ET. The conference call will be
simultaneously webcast on the Company’s web site at www.clovisoncology.com,
and archived for future review. Dial-in numbers for the conference call
are as follows: US participants 866.393.4306, International participants
734.385.2616; conference ID: 5885294.
About Clovis Oncology
Clovis Oncology, Inc. is a biopharmaceutical company focused on
acquiring, developing and commercializing innovative anti-cancer agents
in the U.S., Europe and additional international markets. Clovis
Oncology targets development programs at specific subsets of cancer
populations, and simultaneously develops, with partners, diagnostic
tools intended to direct a compound in development to the population
that is most likely to benefit from its use. Clovis Oncology is
headquartered in Boulder, Colorado, and has additional offices in San
Francisco and Oakland, California and Cambridge, UK. Please visit clovisoncology.com
for more information.
View source version on businesswire.com: https://www.businesswire.com/news/home/20181016005030/en/
Clovis Investor Contacts:
Anna Sussman, 303-625-5022
Source: Clovis Oncology, Inc.
© 2019 Canjex Publishing Ltd. All rights reserved.